White label ELPA - ClinicalTrials.eu

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Not recruiting

3 1
Investigated Diseases:
- Chronic inflammatory demyelinating polyradiculoneuropathy
Investigated Drugs:
- Riliprubart
+7
Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Not recruiting

3 1 1
Investigated Drugs:
- Asundexian
- Apixaban
+16
Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Not recruiting

4 1
Investigated Drugs:
- Azacitidine
+4
Study on Daridorexant for Treating Insomnia in Patients with Insomnia and Nocturia

Not recruiting

3 1 1
Investigated Diseases:
- Nocturia
- Insomnia
Investigated Drugs:
- Daridorexant
Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Monkeypox
Investigated Drugs:
- Tecovirimat
+2
Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Not recruiting

3 1 1
Investigated Diseases:
- Obesity
Investigated Drugs:
- Cagrilintide
- Semaglutide
+8
Study on Vitamin D3 and Glycerol for Reducing Fatigue in Colorectal Cancer Patients with Low Vitamin D Levels After Treatment

Not recruiting

3 1 1
Investigated Diseases:
- Colorectal cancer
Investigated Drugs:
- Glycerol
- Colecalciferol
Live Attenuated Influenza Vaccine (LAIV) and Immune Response in the Nasopharynx of Young Children with Influenza

Not recruiting

3 1 1 1
Investigated Drugs:
- INFLUENZA VIRUS B/AUSTRIA/1359417/2021 – LIKE STRAIN (B/AUSTRIA/1359417/2021, MEDI 355292)
Study on Dexamethasone Film for Patients with Acute Allergic Reactions

Not recruiting

3 1 1 1
Investigated Drugs:
- Dexamethasone
Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Not recruiting

3 1

+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies